Potassium is an essential mineral that helps cells, nerves, and muscles work normally. Human research most consistently links higher potassium intake or potassium interventions with lower blood pressure, especially in studies involving people with high blood pressure; findings for stroke, kidney stones, bone markers, and blood glucose are less certain or depend on the form studied.
It works alongside sodium to help manage fluid balance and electrical signals in the body. The kidneys are central to that balance, which is why potassium needs individual attention when kidney function or medicines affect potassium removal.
Potassium quick facts
| Question | What human research shows |
|---|---|
| Forms found in foods and supplements | Foods contain forms including phosphate, sulfate, and citrate. Supplements commonly use chloride, citrate, phosphate, aspartate, bicarbonate, or gluconate. |
| Doses used in blood-pressure studies | Most potassium chloride trials in the AHRQ review used 20–120 mmol daily, equal to 782–4,692 mg daily. |
| Typical study length | Blood-pressure trials lasted 1–36 months. A recent bone-marker review assessed outcomes from 1 to 12 months. |
| Main studied uses | Blood pressure, sodium-to-potassium balance, stroke associations, calcium-containing kidney stones, bone-turnover markers, and glucose measures. |
| Adult adequate intake | For healthy adults, NIH lists 3,400 mg daily for men and 2,600 mg daily for women ages 19–50; the values differ by age, pregnancy, and lactation. |
A study dose is not a personal dose. The distinction matters when reading a result: ingredient evidence vs marketing claims explains why an ingredient claim should match the actual population, form, and outcome studied.
What do human studies show?
Blood pressure: the strongest evidence
The NIH Office of Dietary Supplements summarizes an AHRQ systematic review in which potassium supplements, mostly potassium chloride, lowered systolic and diastolic blood pressure versus placebo at 20–120 mmol daily over 1–36 months. A National Academies analysis of 16 trials found average reductions of 6.87 mmHg systolic and 3.57 mmHg diastolic; effects were stronger in studies that included people with hypertension and were not statistically significant in studies limited to people without hypertension. Read the underlying evidence summary in the NIH potassium fact sheet.
The sodium relationship is important here. Sodium is the main regulator of fluid outside cells, while potassium helps maintain fluid inside cells. In the AHRQ review, potassium-containing salt substitutes lowered blood pressure, but lowering sodium also reduced blood pressure and adding potassium through food or supplements did not reduce it further. That means a sodium-to-potassium result does not show that potassium alone caused every change.
A 2024 systematic review of placebo-controlled randomized trials in people with normal blood pressure reported that potassium doses of 60 mmol or less daily and durations longer than one month were associated with average systolic reductions of 2.34 and 2.80 mmHg, respectively. Its authors noted that the analysis relied on previously published trials and called for longer follow-up. The 2024 systematic review is useful for seeing the dose and duration subgroups directly.
Stroke and cardiovascular outcomes: associations, not proof of cause
In a meta-analysis of 11 prospective cohort studies involving 247,510 adults, an additional 1,640 mg daily of potassium intake was associated with a 21% lower stroke risk. A separate meta-analysis of 16 cohort studies totaling 639,440 participants found a 15% lower stroke risk in the highest versus lowest intake groups. These are observational studies: they can identify a pattern but cannot prove that potassium itself produced the difference.
The NIH fact sheet also reports that AHRQ found inconsistent relationships between dietary potassium and stroke across 15 observational studies. That conflict is why the clearest practical conclusion stays with the trial outcome—blood pressure—rather than treating observational stroke findings as a guarantee. A 2023 Johns Hopkins nutrition review likewise describes potassium intake and sodium intake as major factors related to blood-pressure levels.
Kidney stones: dietary patterns and citrate are different questions
Two large cohort studies linked higher dietary potassium intake with lower kidney-stone risk: 45,619 men followed for four years and more than 90,000 women followed for 12 years. Those findings are associations.
For supplements, a Cochrane Review of seven studies and 477 people with mostly calcium oxalate stones found potassium citrate salts reduced new stones and stone size. The NIH fact sheet explains an important limit: citrate itself may be responsible because it binds urinary calcium and raises urine pH. This result should not be read as evidence that every potassium form has the same effect.
Bone markers: small and mixed findings
A 2026 systematic review and meta-analysis included five randomized controlled trials with 401 postmenopausal women. Potassium citrate lowered one urinary bone-resorption marker, NTX, at one month versus placebo, but did not significantly change CTX or P1NP at the later time points studied. The authors judged the clinical importance uncertain and said larger, longer trials are needed. See the 2026 bone-marker review.
In plain terms, a bone-turnover marker is a lab measure connected with bone breakdown or formation; it is not the same as showing fewer fractures. This is the kind of outcome distinction covered in zinc benefits evidence.
Blood glucose: one small trial, with an unfinished answer
The NIH fact sheet describes a three-month clinical trial in 29 African American adults with prediabetes and low-to-normal serum potassium. Researchers used 40 mEq, or 1,564 mg, of potassium chloride daily. Fasting glucose fell, but glucose and insulin measures during an oral glucose-tolerance test did not change. The fact sheet concludes that more randomized trials are needed before potassium’s link with glucose control can be confirmed.
What doses did researchers use?
Researchers used different forms and amounts for different questions. These figures describe the studies; they are not instructions for self-treatment.
| Research question | Form and amount studied | Duration | What was measured |
|---|---|---|---|
| Blood pressure in AHRQ-reviewed trials | Mostly potassium chloride, 20–120 mmol daily (782–4,692 mg) | 1–36 months | Systolic and diastolic blood pressure |
| Normal-blood-pressure subgroup analysis | Potassium at 60 mmol daily or less | More than 1 month | Systolic blood pressure |
| Prediabetes pilot trial | Potassium chloride, 40 mEq (1,564 mg) daily | 3 months | Fasting glucose and oral glucose-tolerance measures |
| Bone-marker review | Potassium citrate; individual trial amounts vary | 1–12 months | NTX, CTX, P1NP, and related markers |
Amounts on nutrition labels are reported as elemental potassium, not the total weight of the potassium-containing compound. One mmol equals 39.1 mg of potassium, according to NIH.
Safety, side effects, and medicine interactions
For healthy people with normal kidney function, high potassium intake from food generally does not pose a health risk because the kidneys remove excess potassium in urine, according to the NIH fact sheet. Very large supplemental amounts have been linked in case reports to heart abnormalities and death, although the National Academies found the reports insufficient to set a general upper intake level.
High blood potassium can cause muscle weakness and irregular heart rhythms. Low potassium intake can increase blood pressure, kidney-stone risk, bone turnover, urinary calcium loss, and salt sensitivity. Severe deficiency is called hypokalemia; low potassium can also arise when the body loses potassium through severe vomiting or diarrhea, or with certain medicines.
Potassium needs extra care with kidney disease and medicines that impair potassium excretion. A 2023 Johns Hopkins review notes that some blood-pressure medicines that block the renin-angiotensin system can raise potassium levels. Do not start, stop, or change a prescribed medicine based on an ingredient page; a clinician can assess the medication and potassium context together.
Who should talk to a clinician first?
- Anyone with kidney disease or another condition that impairs potassium excretion.
- Anyone using a medicine that can affect potassium removal, including certain blood-pressure medicines.
- Anyone with a known high or low blood-potassium result.
- Anyone considering a potassium supplement or potassium-based salt substitute to address symptoms or a lab result.
- Anyone with ongoing severe vomiting or diarrhea, or new muscle weakness or an irregular heartbeat.
The adult adequate-intake values do not apply to people with impaired potassium excretion because of medical conditions or medicines, NIH notes.
What is still unknown?
- Whether higher dietary potassium itself lowers stroke risk; the existing cohort findings are associations and AHRQ found them inconsistent.
- Whether potassium supplements broadly reduce kidney-stone risk, separate from the role of citrate in potassium citrate studies.
- Whether potassium citrate changes meaningful long-term bone outcomes in postmenopausal women.
- Whether potassium supplementation improves glucose control beyond the small three-month pilot trial.
- Which potassium form is “best” for heart health. The available studies assess specific forms and outcomes, not a universal best form.
- A single sodium-to-potassium ratio that applies to every person. The global review reported an average urinary ratio of 3.68 across 43 studies, while individual needs can differ substantially when kidney function or medicines are involved.
How to read a label that lists potassium
Start with the Supplement Facts panel. It should state the amount of elemental potassium per serving and the percent Daily Value. The FDA Daily Value is 4,700 mg for adults and children age four and older; it is a label reference value, not a study dose or an individual prescription.
| Label detail | Why it matters |
|---|---|
| Amount of potassium per serving | Compare the elemental-potassium amount, not just the size of the tablet or compound name. NIH says many multivitamins that include potassium provide about 80 mg, and many potassium-only supplements provide up to 99 mg. |
| Form | Look for chloride, citrate, gluconate, phosphate, bicarbonate, aspartate, or another named form. |
| Serving size | Check whether the listed amount applies to one capsule, a scoop, or several units. |
| Proprietary blend | If a blend does not state the amount of potassium, it cannot be matched to a research amount. |
| Salt substitute | Potassium content varies widely: NIH reports about 440–2,800 mg per teaspoon across products. |
When a label uses a form name without an elemental-potassium amount, ask the manufacturer for that amount before making any comparison with a study. That small check keeps a label claim separate from the amount researchers actually tested.
By ClinicalStudyConnect.com Research Desk
This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.